Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2021		Dec. 31, 2020
Current Assets
Cash and cash equivalents	$ 536		$ 955
Trade receivables - third party and affiliates	1,161		792
Non-trade receivables, net	506		450
Inventories	1,524		978
Marketable securities	10		533
Other assets	70		55
Total current assets	3,807		3,763
Investments in affiliates	823		820
Property, plant and equipment (net of accumulated depreciation - 2021: $3,484; 2020: $3,279)	4,193		3,939
Operating lease right-of-use assets	236		232
Deferred income taxes	248		259
Other assets	521		411
Goodwill	1,412	[1]	1,166
Intangible assets, net	735		319
Total assets	11,975		10,909
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates	791		496
Trade payables - third party and affiliates	1,160		797
Other liabilities	473		680
Income taxes payable	81		0
Total current liabilities	2,505		1,973
Long-term debt, net of unamortized deferred financing costs	3,176		3,227
Deferred income taxes	555		509
Uncertain tax positions	280		240
Benefit obligations	558		643
Operating lease liabilities	200		208
Other liabilities	164		214
Commitments and Contingencies
Stockholders' Equity
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2021 and 2020: 0 issued and outstanding)	0		0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2021: 169,760,024 issued and 108,023,735 outstanding; 2020: 169,402,979 issued and 114,168,464 outstanding)	0		0
Treasury stock, at cost (2021: 61,736,289 shares; 2020: 55,234,515 shares)	(5,492)		(4,494)
Additional paid-in capital	333		257
Retained earnings	9,677		8,091
Accumulated other comprehensive income (loss), net	(329)		(328)
Total Celanese Corporation stockholders' equity	4,189		3,526
Noncontrolling interests	348		369
Total equity	4,537		3,895
Total liabilities and equity	$ 11,975		$ 10,909

[1] There were no accumulated impairment losses as of December 31, 2021.